பெஞ்சமின் வாட்கின்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெஞ்சமின் வாட்கின்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெஞ்சமின் வாட்கின்ஸ் Today - Breaking & Trending Today

patient gets surprise last minute donor Acute myeloid leukemia

After Sofia learned she had cancer, her sister stepped in when she needed it most.
Author: Liza Lucas
Updated: 8:45 AM EST January 28, 2021
ATLANTA From shared laughs to shared adventures, Sofia and Bella Irlando have grown up together. The sisters side by side in the good times, and the hard ones, too.
Such bonds of sisterhood were put to the test after Sofia received the news she had acute myeloid leukemia, a cancer of the blood and bone marrow.
It was obviously very scary, it was very stressful, Sofia told 11Alive of her diagnosis.
The news meant not only rounds of chemotherapy for Sofia, but the need for a bone marrow transplant. ....

Bella Irlando , Atlanta Egleston , Benjamin Watkins , Blood Disorders Center , Aflac Cancer , அட்லாண்டா எகிலேஸ்தோங் , பெஞ்சமின் வாட்கின்ஸ் , இரத்தம் கோளாறுகள் மையம் ,

Arthritis Drug Cuts GVHD Risk in Stem Cell Transplants

email article
A widely used arthritis drug reduced the rate of acute graft-versus-host disease (GVHD) in both HLA-matched and -mismatched allogeneic stem-cell transplants, a randomized study showed.
The incidence of grade 3/4 acute GVHD after matched transplants decreased from 14.8% with standard prophylaxis to 6.8% with the addition of abatacept (Orencia). In a small group of patients who had 7/8-HLA-mismatched transplants, grade 3/4 acute GVHD at day 100 declined significantly from 30.2% with standard prophylaxis to 2.3% with add-on abatacept (
P 0.001).
Treatment with abatacept was not associated with increased rates of disease relapse or infection, investigators reported in the
We found really striking results, particularly with those who were mismatched stem-cell transplants, in preventing acute GVHD, said Benjamin Watkins, MD, of Aflac Cancer and Blood Disorders Center and Emory University in Atlanta. This was a pretty rigorously run trial . and ....

Charles Bankhead , Muna Qayed , Benjamin Watkins , Emory University In Atlanta , Blood Disorders Center , Emory University , Marrow Transplant Research , Aflac Center , Aflac Cancer , Medpage Today , Clin Oncol , Graft Versus Host Disease , சார்லஸ் வங்கித் தலை , பெஞ்சமின் வாட்கின்ஸ் , உணர்ச்சி பல்கலைக்கழகம் இல் அட்லாண்டா , இரத்தம் கோளாறுகள் மையம் , உணர்ச்சி பல்கலைக்கழகம் , மஜ்ஜை மாற்று ஆராய்ச்சி , ஒட்டு எதிராக தொகுப்பாளர் நோய் ,